-- 
Azrieli, Bezeq, Teva, Koor and Granite: Israeli Equity Preview

-- B y   S h o s h a n n a   S o l o m o n
-- 
2011-10-05T07:42:51Z

-- http://www.bloomberg.com/news/2011-10-05/azrieli-bezeq-teva-koor-and-granite-israeli-equity-preview.html
The following stocks may rise or fall
in Israeli markets. Stock symbols are in parentheses after
company names and prices are from the last close unless
otherwise stated.  The TA-25 Index tumbled 3.8 percent to 1,020.92 in  Tel
Aviv .  Azrieli Group (AZRG)  Ltd: The real estate company is in
talks to sell its  Granite Hacarmel Investments Ltd. (GRNT)  
and Sonol Israel Ltd. units, Calcalist reported. “A number of
people have approached us for the acquisition of Granite,”
Azrieli Group said in a statement read by telephone. Azrieli
shares rose 0.7 percent to 85.17 shekels. Granite, a marketer of
petroleum and automobile products, increased 0.1 percent to
5.248 shekels.  Bezeq Israeli Telecommunication Corp. (BEZQ IT): The
country’s largest communications company is studying yesterday’s
recommendations by a Ministry of Communications committee that
would require companies that own nationwide telecommunication
networks to lease space to newcomers who will compete with them
in the local market. The shares rose 1 percent to 6.845 shekels.  Koor Industries Ltd. (KOR)  :  Discount Investment Corp. (DISI) 
 raised its offer to acquire 3.3 million shares of the
holding company to 38.5 shekels a share from 35 shekels. Koor
shares fell 4.3 percent to 34.91 shekels. Discount shares lost
0.7 percent to 31 shekels.  Teva Pharmaceutical Industries Ltd. (TEVA)  : Merck KGaA’s
Merck Serono unit will develop and market a pill for multiple
sclerosis with  Japan ’s Ono Pharmaceutical Co. Teva, whose best
selling product is a multiple sclerosis drug and which is
developing the pill laquinimod to treat the disease, slid 5.3
percent to 133 shekels.  To contact the reporter on this story:
Shoshanna Solomon in Tel Aviv at 
 ssolomon22@bloomberg.net   To contact the editor responsible for this story:
Claudia Maedler at 
 cmaedler@bloomberg.net  